Stay updated with breaking news from Research Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NTN Corporation announced that at the Board of Directors meeting held on February 26, 2024, the Company has made its decision of the following change of Executive Officers effective...
InTEST Corporation Fourth Quarter 2024 Teleconference Call and Webcast ...
The first-in-class oral factor D inhibitor danicopan (Voydeya) has been approved for the management of extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH).
Concert attendees are braving the elements as climate change accelerates, sometimes with grave consequences.
Affirm Holdings, Inc. NasdaqGS:AFRM Affirm Fireside Chat with Wells Fargo Friday, March 22, 2024 4:00 PM GMT Call...